We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Premier Veterinary Group Plc | LSE:PVG | London | Ordinary Share | GB00BSZLMS59 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.50 | 32.00 | 37.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMAKT
RNS Number : 5202Z
Ark Therapeutics Group PLC
11 December 2014
ARK THERAPEUTICS GROUP PLC
Results of General Meeting
London, UK, 11 December 2014 (LSE: AKT): Ark Therapeutics Group plc ("Ark" or the "Company") announces that at the Company's General Meeting held earlier today all resolutions were duly passed. A summary of the votes lodged by proxy is set out below:
No Resolution Votes for % Discretion % Votes % Votes withheld against Proposed transfer 1 to standard list 73,699,781 92.23 6,189,396 7.75 15,237 0.02 38,050 Adoption of 2014 Executive Option 2 Plan 73,692,058 92.25 6,175,245 7.73 17,609 0.02 57,552 Adoption of 2014 3 EMI Plan 73,692,058 92.25 6,175,245 7.73 17,609 0.02 57,552 Approval of Directors' remuneration 4 policy 68,157,170 85.39 6,175,245 7.73 5,486,957 6.87 122,552 Approval of the 5 Rule 9 waiver 73,703,875 99.74 175,245 0.24 17,309 0.02 46,053 Approval of the Terms of the 6 Subscription 73,639,630 92.24 6,175,245 7.73 17,309 0.02 110,550 Authority to 7 allot shares 73,631,243 92.18 6,233,362 7.80 17,309 0.02 60,550 Disapplication of pre-emption 8 rights 73,627,226 92.16 6,248,362 7.82 17,309 0.02 49,567 Share capital 9 reorganisation 73,605,664 92.12 6,233,362 7.80 65,388 0.08 38,050 Amendments to Articles of 10 Association 73,558,743 92.16 6,248,513 7.82 17,158 0.02 88,050 11 Name change 73,605,664 92.17 6,233,362 7.81 15,388 0.02 88,050
For further information please contact:
Ark Therapeutics Group plc Tel: +44(0)203 755 5160 Iain G Ross, Non-Executive Chairman Sue Steven, Non-Executive Director
This information is provided by RNS
The company news service from the London Stock Exchange
END
ROMBDBDDBSBBGSB
1 Year Premier Veterinary Chart |
1 Month Premier Veterinary Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions